Inhibitor of angiotensin-converting enzyme modifies myointimal origin in an arterial autograft model

Challenging Alexis Carrel: a study in alternate microvascular techniques

INTRODUCTION

Alexis Carrel pioneered the full-thickness triangulated vascular repair technique, which led to a Nobel Prize in 1912. However, microvascular anastomotic techniques that do not violate the intima, such as the VCS microclip repair and partial-thickness suturing, limit trauma to the intima, thus minimizing the potential for thrombosis. Our study compares such techniques with the standard full thickness-anastomotic repair.

METHODS

Thirty-two end-to-end anastomotic repairs were performed in rat femoral arteries 1 mm or less in diameter. Group I: thirteen full-thickness repairs were completed using 10-0 nylon on a BV75 microm needle. Nineteen extraluminal repairs were performed using either a partial thickness technique with an 11-0 nylon BV50 microm needle (Group II, n = 12) or VCS nonpenetrating clip (Group III, n=7). Casted samples, injected with methylmethacrylate, were harvested at 1 and 3 weeks for histopathological evaluation. The presence of thrombosis, inflammation, endothelialization, angiogenesis and intimal hyperplasia were described for each repair.

RESULTS

Statistical analysis revealed no difference between the intraluminal and extraluminal techniques. Patency rates were similar between both groups: 92% (12/13) for Group I and 94% (17/18) for the extraluminal Groups II and III combined. One-hundred per cent of partial thickness suture repairs were patent. Histology revealed localized inflammation to the adventitia and media, as well as endothelialization at 1 week for anastomoses in Groups II and III. The intima of Group I demonstrated proliferative characteristics in contrast to the extraluminal groups, where secretory myofibroblasts were prevalent. The anastomotic microcirculation did not originate from the repaired artery in any of the groups.

CONCLUSION

Patency rates with end-to-end anastomotic repairs using a partial thickness technique are comparable to the standard full-thickness technique. Repairs that do not include the intima revealed focal inflammatory responses to the outer layers and more rapid endothelialization, while neighboring vessels perfuse the healing anastomosis.

Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation

Long-term renin-angiotensin system blockade is beneficial in a variety of renal diseases. This study examines the long-term (34 weeks) effects of the angiotensin-converting enzyme inhibitor lisinopril and the angiotensin II receptor type I blocker L158,809 in the Fisher to Lewis rat model of chronic renal transplant failure. Treatment in allografted rats with lisinopril or L158,809 was initiated 10 days after transplantation, or at the time when proteinuria exceeded 50 mg/24 h. Untreated allografts and syngrafts served as controls. In contrast to syngrafts, untreated allografts developed proteinuria, hypercholesterolaemia, interstitial damage, and glomerulosclerosis. Lisinopril or L158,809 treatment in allografts starting at day 10 after transplantation completely prevented this, with the exception of interstitial damage, but this treatment also caused a reduction in blood pressure and renal function. Moreover, the intimal surface area of the renal arteries was dramatically increased in allografts treated with either lisinopril or L158,809 compared with untreated allografted rats. Treatment once proteinuria had developed was less effective in preventing glomerulosclerosis, but also caused less intimal expansion. Thus, chronic renin-angiotensin system blockade preserves glomerular morphology in the absence of proteinuria, but enhances intimal hyperplasia and reduces renal function in experimental transplantation. In view of these results, it should be questioned whether such treatment benefits renal transplant patients in the long term.

Effects of a venous cuff at the venous anastomosis of polytetrafluoroethylene grafts for hemodialysis vascular access

INTRODUCTION AND METHODS

The most frequent complication of polytetrafluoroethylene (PTFE) arteriovenous grafts for hemodialysis is thrombotic occlusion due to stenosis caused by intimal hyperplasia. This complication is also known for peripheral bypass grafts. Because the use of a venous cuff at the distal anastomosis improves the patency of peripheral bypass grafts, we considered that it might also improve the patency of PTFE arteriovenous grafts. Therefore, a randomized multicenter trial was carried out to study the effect of a venous cuff at the venous anastomosis of PTFE arteriovenous grafts on the development of stenoses and the patency rates.

RESULTS

Of the 120 included patients, 59 were randomized for a venous cuff. The incidence of thrombotic occlusion was lower in the cuff group (0.68 per patient-year) than in the no-cuff group (0. 88 per patient-year; P =.0007). However, the primary and secondary patency rates were comparable. The cuff group tended to have fewer stenoses at the venous and arterial anastomoses when examined with duplex scan. Graft failure was higher in patients with an initial anastomosing vein diameter smaller than 4 mm (7 of 18 [39%]) than in those with a vein diameter of 4 mm or larger (16 of 88 [18%]; P =. 052). Local edema, skin atrophy, and obesity yielded a higher risk on graft failure (23% vs 11%).

CONCLUSION

A venous cuff at the venous anastomosis of PTFE arteriovenous grafts for hemodialysis reduced the incidence of thrombotic occlusions; stenosis at the venous anastomosis was reduced. However, this did not result in a better patency rate. Therefore, the venous cuff should not be used routinely. Initial vein diameter and local problems (edema, obesity, or skin atrophy) appear to be the most important risk factors for graft failure.